News
Project news, updates, and announcements.
Second German hospital registers participants in EUPHORIA IBD Study
The EUPHORIA study
The EUPHORIA study is now open at the Universitätsklinikum Jena, Klinik für Innere Medizin IV in Jena, Germany. This is the second clinical study site running the EUPHORIA study in Germany and they are currently recruiting patients to take part. Two patients are already registered and scanned with the MSOT Acuity system as of Tuesday, September 14th.
The Pricipal Investigator of the EUPHORIA study in Jena is Prof. Dr. Andreas Stallmach, Universitätsklinikum Jena, Klinik für Innere Medizin IV, Am Klinikum 1, 07747 Jena. The Study Coordinator is Dr. rer. nat. Anja Schauer, email: Phone: +49 3641-9324582
iThera leads €1.9m research project to advance optoacoustic imaging technology towards AI-supported quantitative medical diagnosis
EUPHORIA Coordinators, iThera Medical GmbH has received grant funding from the Bavarian Ministry of Economic Affairs, Regional Development and Energy to conduct a Euro 1.9 million R&D project to develop next-generation AI-supported electronics for its MSOT imaging systems for inflammatory bowel disease. The Bavarian state-funded technology innovation project, DeepOPUS, launched today, September 13th, 2021, aims to augment iThera’s proprietary optoacoustic imaging technology using AI technology, developing it into a quantitative diagnostic method for inflammatory bowel disease (IBD) and beyond. Stefan Morscher, the project leader of DeepOPUS and VP of Software Development at iThera Medical: ‘We are extremely excited to lift clinical diagnostics to a new level through the introduction of groundbreaking AI technology in an MSOT device. This will make the technology applicable to a wider patient population.’
This is an important next step to further translate the groundbreaking MSOT technology from research use to clinical routine. Read the full press release here.
The DeepOPUS project is funded through the Bavarian Ministry of Economic Affairs, Regional Development and Energy (Bayerisches Staatsministerium für Wirtschaft, Landesentwicklung und Energie) under grant agreement No DIE-2106-0004 // DIE0161/01.
iThera Medical showcases MSOT Acuity system at European Molecular Imaging Meeting
After more than a year of COVID-induced conference cancellations, the iThera Medical team is thrilled to be back amongst their users and imaging scientists at #EMIM2021, the European Molecular Imaging Meeting, hosted this year by the University Medical Center in Göttingen. Neal Burton, Tim Devling and Christian Wiest tend their shiny new booth, refurbished for the occasion! Visit the booth to learn more about their MSOT Echo and RSOM technologies.
The European Molecular Imaging Meeting runs this week, August 24th – 26th.
EUPHORIA plenary meeting, June 2021
The EUPHORIA team met online on 18 June 2021 for our bi-annual plenary meeting. There was exciting progress to discuss as all ethics and regulatory approvals for the EUPHORIA study have now been received. A CE Mark has recently been awarded to the MSOT Acuity Echo. Opening the study and recruitment across all sites will be a major focus for the months ahead.
EUPHORIA CE mark announcement featured by CORDIS
The Community Research and Development Information Service (CORDIS), the European Commission’s primary source of results from the projects funded by the EU’s framework programmes for research and innovation featured EUPHORIA news on June 23rd, 2021. The mission of CORDIS is to bring research results to professionals in the field to foster open science, create innovative products and services and stimulate growth across Europe.
The CORDIS announcement reads: “German medical technology manufacturer iThera Medical’s imaging system has been awarded a CE mark, confirming that the product conforms with European health, safety and environmental protection standards. The system in question uses a new imaging modality named multispectral optoacoustic tomography (MSOT). As such, it’s called the MSOT Acuity Echo. The non-invasive MSOT Acuity Echo device combines lasers and ultrasound and has the potential to provide better monitoring of IBD than current imaging systems. The device’s journey to CE certification was supported by the EU-funded EUPHORIA project that has focused on optimising the technology and testing the device as a clinical tool for non-invasively monitoring IBD.”
Read the entire story, available in six languages, here.
The EUPHORIA study presented at Australian Society of Molecular Imaging June 2021 meeting
Tim Devling of iThera Medical was an invited speaker at the National Meeting of the Australian Society of Molecular Imaging. Tim’s talk took place on June 21st and was titled “Multispectral Optoacoustic Tomography (MSOT): The path towards clinical translation.” In his talk, Tim presented the EUPHORIA project and study.
The meeting took place in person and online June 21st-23rd, 2021. In attendance, seventy people were present in Brisbane and 200 attended online.
The 6th Annual Scientific Symposium hosted by the Australian Society of Molecular Imaging (ASMI) brings together researchers from a wide range of disciplines interested in the development and application of multi-modality molecular imaging. Find the meeting program here.
IMASONIC SAS in the Spotlight
Headquartered near Besançon in the Franche-Comté region of France with 120 employees, IMASONIC (https://www.imasonic.com/en/home/) is an SME using the best tools currently available for the design, manufacture and characterization of custom ultrasound transducers for a large range of innovative applications.
IMASONIC benefits from a thirty-year track record in design and manufacturing and as such, their production capacity is organized for customized, series or prototype production. Their teams work collaboratively within an assemblage of national and international projects and partners. IMASONIC possesses an array of experience with numerous innovations in the medical and industrial fields. Their quality management system is in accordance with ISO 9001: 2015 and covers all of the company’s activities, namely: the design, manufacture and sale of ultrasonic transducers, associated services and after-sales services. The company strives to improve customer satisfaction, their processes in compliance with customer requirements as well as all applicable regulatory requirements.
Introducing Dr Frédéric Brochin, R&D Project Manager at IMASONIC. We posed a few questions to Frédéric about his role, the company and background to IMASONIC’s involvement in EUPHORIA.
Please tell us a bit about yourself and your background in materials science and R&D.
My background is in Materials Science and Engineering, especially the processes of fabrication and characterization of materials. During my PhD thesis, I have been working on the fabrication of nanocomposite materials and […]